secwatch.observer — SEC 8-K summary
======================================

Issuer:     TriSalus Life Sciences, Inc. (TLSI)
CIK:        0001826667
Form:       8-K
Filed at:   2024-06-27T23:59:59+00:00
Accession:  0001104659-24-075234
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.03, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TriSalus completes warrant exchange; 78.9% of public warrants tendered; warrant amendment enacted
--------------------------------------------------------------------------------

- 6,533,614 Public Warrants (78.89%) tendered for 0.30 shares each; settlement by July 1, 2024.
- 504,685 Private Placement Warrants (10.23%) and 0 Working Capital Warrants tendered.
- Warrant Amendment approved for Public Warrants; allows company to force conversion of remaining warrants at 0.27 shares (10% discount).
- Registration statement on Form S-4 declared effective by SEC on June 25, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826667/000110465924075234/0001104659-24-075234-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826667/000110465924075234/tm2418344d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-075234

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer